Atlas Trials

Efficacy of Melatonin in Decreasing the Incidence of Delirium in End of Life Patients

Clinical trial NCT02536417 · COMPLETED

Trial details

NCT number
NCT02536417
Sponsor
Fraser Health
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Delirium
Start date
2016-06-29
Primary completion
2020-09-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.